Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
Clinical trial NCT03709758 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03709758
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2025-02-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.